Skip to main content
. 2021 Aug 5;10(16):3469. doi: 10.3390/jcm10163469

Table 1.

Anthropometric, metabolic, inflammatory markers and PA comparison between PCOS group (PCOS) and control group (CONTROL).

Variables PCOS
n = 61
CONTROL
n = 35
p-Value
Age (years) 0.125
median (25–75%) 16 (15–17) 15 (15–17)
Body height (m) 0.876
mean(sd) 166.2(6.09) 166.4(6.17)
Body weight (kg) 0.159
median (25–75%) 62.3 (52.8–77.5) 56.9 (53.25–62.25)
BMI categories 0.001
Underweight 2 (3.28%) 0
Healthy weight 37 (60.66%) 34 (97.14%)
Overweight/Obesity 22 (36.07%) 1 (2.86%)
IL-1 (pg/mL) 0.116
median (25–75%) 24.7 (18.93–32.35) 22.75 (15.09–29.87)
IL-6 (ng/L) 0.189
median (25–75%) 28.15 (22.72–36.89) 24.33 (18.19–43.15)
TNF-α (ng/L) 0.313
median (25–75%) 74.54 (56.37–107.8) 85.16 (64.8–98.2)
CRP (mg/L) 0.010
median (25–75%) 0.71 (0.35–1.3) 0.41 (0.28–0.58)
TC (mg/dL) 0.096
median (25–75%) 158 (135.2–174.4) 145.3 (125.6–165.4)
LDL-C (mg/dL) 0.013
median (25–75%) 80.3 (64.3–98.2) 65.4 (57.6–81.15)
HDL-C (mg/dL) 55.42(10.4) 58.27(14.07) 0.300
mean(sd)
TG (mg/dl) 0.228
median (25–75%) 84.5 (66.7–117.4) 75.6 (58.05–106.45)
Fasting glucose (mmol/L) 0.942
median (25–75%) 88.1 (84.48–92.5) 90.4 (81.75–93.75)
Fasting insulin (mU/mL) 0.002
median (25–75%) 14.36 (9.35–19.11) 9.74 (7.73–13.06)
HOMA-IR 0.006
median (25–75%) 2.94 (1.87–4.36) 2.24 (1.64–2.8)
WC (cm) <0.001
median (25–75%) 76 (68–87) 65.5 (64.25–67)

Abbreviations: PCOS, polycystic ovary syndrome; IL-1-interleukin-1; IL-6-interleukin-6; TNF-α-Tumor Necrosis Factor α; CRP-C-reactive protein; TC-total cholesterol; LDL-C—low-density lipoprotein cholesterol; HDL-C—high-density lipoprotein cholesterol; TG-triglycerides; HOMA-IR-Homeostatic Model Assessment of Insulin Resistance; WC—Waist Circumference. All the p-values marked in bold were statistically significant.